Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Inventory Average (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Inventory Average for 13 consecutive years, with $19.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average rose 98.7% to $19.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.6 million, a 98.7% increase, with the full-year FY2025 number at $14.8 million, up 24.87% from a year prior.
  • Inventory Average was $19.6 million for Q4 2025 at Niagen Bioscience, up from $16.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $19.6 million in Q4 2025 to a low of $9.9 million in Q4 2024.
  • A 5-year average of $13.5 million and a median of $13.2 million in 2021 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: fell 27.3% in 2024, then surged 98.7% in 2025.
  • Niagen Bioscience's Inventory Average stood at $13.1 million in 2021, then rose by 15.36% to $15.2 million in 2022, then fell by 10.44% to $13.6 million in 2023, then dropped by 27.3% to $9.9 million in 2024, then soared by 98.7% to $19.6 million in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Inventory Average are $19.6 million (Q4 2025), $16.6 million (Q3 2025), and $12.8 million (Q2 2025).